Vulnerability   
Search   
    Search 324607 CVE descriptions
and 145615 test descriptions,
access 10,000+ cross references.
Tests   CVE   All  

Test ID:1.3.6.1.4.1.25623.1.0.806665
Category:Web application abuses
Title:TYPO3 Multiple Cross-Site Scripting Vulnerabilities (Jan 2016)
Summary:TYPO3 is prone to multiple cross-site scripting vulnerabilities.
Description:Summary:
TYPO3 is prone to multiple cross-site scripting vulnerabilities.

Vulnerability Insight:
Multiple flaws exist due to:

- An error in authorized editors which can insert javascript commands by using
the url scheme 'javascript:'.

- An error in editor where input passed to editor is not properly encoded.

- An error while HTML encode extension data during an extension installation.

- An error while encoding user input.

Vulnerability Impact:
Successful exploitation will allow
remote attackers to execute arbitrary script code in a user's browser session
within the trust relationship between their browser and the server.

Affected Software/OS:
TYPO3 versions 6.2.x before 6.2.16 and 7.x
before 7.6.1

Solution:
Upgrade to TYPO3 version 6.2.16 or 7.6.1
or later.

CVSS Score:
4.3

CVSS Vector:
AV:N/AC:M/Au:N/C:N/I:P/A:N

Cross-Ref: Common Vulnerability Exposure (CVE) ID: CVE-2015-8759
BugTraq ID: 79250
http://www.securityfocus.com/bid/79250
Common Vulnerability Exposure (CVE) ID: CVE-2015-8758
BugTraq ID: 79240
http://www.securityfocus.com/bid/79240
http://www.securitytracker.com/id/1034484
Common Vulnerability Exposure (CVE) ID: CVE-2015-8757
BugTraq ID: 79254
http://www.securityfocus.com/bid/79254
http://www.securitytracker.com/id/1034482
Common Vulnerability Exposure (CVE) ID: CVE-2015-8755
BugTraq ID: 79236
http://www.securityfocus.com/bid/79236
http://www.securitytracker.com/id/1034483
CopyrightCopyright (C) 2016 Greenbone AG

This is only one of 145615 vulnerability tests in our test suite. Find out more about running a complete security audit.

To run a free test of this vulnerability against your system, register below.




© 1998-2025 E-Soft Inc. All rights reserved.